Eurasian Academy of Medicine and Dentistry Eurasian Academy of Medicine and Dentistry

Journal of Applied Pharmaceutical Technologies and Systems
ISSN: 3149-9589
Submit your manuscript Review for us

Aims and Scope

The Journal of Applied Pharmaceutical Technologies and Systems (ISSN: 3149-9589), published by Eurasian Academy of Medicine and Dentistry (EAMD), is an international, peer-reviewed, open access journal devoted to the science, engineering, development, manufacture, evaluation, and implementation of pharmaceutical technologies and production systems. The journal connects pharmaceutical sciences with process engineering, formulation science, manufacturing technology, quality systems, automation, and emerging tools that improve the development and reliable production of medicines.

The journal welcomes original research articles, review articles, systematic reviews, methodological papers, technical studies, case-based industrial analyses, and interdisciplinary contributions addressing pharmaceutical products and the systems used to design, manufacture, control, scale, package, store, and deliver them.

The journal’s scope includes:

  • Pharmaceutical technology and pharmaceutical engineering, including equipment, unit operations, process design, and production technologies

  • Drug formulation and dosage-form development, including solid, liquid, semisolid, inhaled, transdermal, sterile, and other pharmaceutical preparations

  • Drug delivery systems and advanced delivery technologies, including controlled, targeted, sustained-release, and responsive delivery platforms

  • Pharmaceutical process development, optimization, scale-up, technology transfer, and process validation

  • Pharmaceutical manufacturing systems, including batch, continuous, modular, flexible, and decentralized manufacturing

  • Process Analytical Technology (PAT), Quality by Design (QbD), design of experiments, process monitoring, and real-time quality assurance

  • Pharmaceutical quality control, quality assurance, Good Manufacturing Practice (GMP), contamination control, and manufacturing compliance

  • Automation, robotics, digitalization, cyber-physical systems, digital twins, and data-driven control in pharmaceutical manufacturing

  • Modeling, simulation, optimization, and computational methods for pharmaceutical processes and production systems

  • Pharmaceutical materials, excipients, powders, granulation, mixing, coating, tableting, encapsulation, and particle engineering

  • Sterile manufacturing, aseptic processing, lyophilization, biologics manufacturing technologies, and advanced production environments

  • Nanopharmaceuticals, nano-enabled drug delivery, pharmaceutical nanotechnology, and manufacturing considerations for nanoscale formulations

  • Biopharmaceutical processing and manufacturing technologies where the principal contribution concerns process, formulation, production, or quality systems

  • Packaging technologies, container-closure systems, stability, storage, cold-chain considerations, and product robustness

  • Manufacturing sustainability, energy and resource efficiency, waste reduction, green pharmaceutical engineering, and lifecycle-oriented production

  • Supply, distribution, traceability, serialization, and integrated pharmaceutical production systems where these are directly linked to product quality, manufacturing performance, or technology implementation

  • Regulatory science and validation studies directly related to pharmaceutical technology, manufacturing processes, production systems, and product quality

  • The journal also welcomes translational and industrial studies that evaluate the performance, robustness, safety, scalability, reproducibility, economic feasibility, or regulatory readiness of pharmaceutical technologies and manufacturing systems.

Submissions must demonstrate a clear and substantial connection to pharmaceutical technology, pharmaceutical engineering, drug-product development, manufacturing, process systems, or production quality. Manuscripts focused solely on clinical outcomes, general chemistry, general biology, healthcare administration, or computational methods without a meaningful pharmaceutical technology or manufacturing application are outside the journal’s scope.